272 related articles for article (PubMed ID: 20605246)
21. Survival and clinical evaluation of salvage operation for cervical lymph node recurrence in esophageal cancer.
Komatsu S; Shioaki Y; Ichikawa D; Hamashima T; Kan K; Ueshima Y; Koide K; Lee CJ; Ikeda E; Mutoh F; Kurioka H; Oka T; Yamagishi H
Hepatogastroenterology; 2005; 52(63):796-9. PubMed ID: 15966207
[TBL] [Abstract][Full Text] [Related]
22. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
[TBL] [Abstract][Full Text] [Related]
23. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
Mariette C; Taillier G; Van Seuningen I; Triboulet JP
Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
[TBL] [Abstract][Full Text] [Related]
24. Multi-modality treatment in oesophageal cancer: a curse for radiotherapy progress.
Tait DM
Radiother Oncol; 2004 Nov; 73(2):115-7. PubMed ID: 15542157
[No Abstract] [Full Text] [Related]
25. [A prospective comparison between surgery alone and postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma].
Cao XF; Lü J; Zhu B; An HY; Wang S; Wu BC; Ji L; Tao L; Wang DD
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):452-5. PubMed ID: 20819489
[TBL] [Abstract][Full Text] [Related]
26. Value of postoperative radiotherapy in patients with pathologic N1 neck disease.
Jäckel MC; Ambrosch P; Christiansen H; Martin A; Steiner W
Head Neck; 2008 Jul; 30(7):875-82. PubMed ID: 18302275
[TBL] [Abstract][Full Text] [Related]
27. Total number of resected lymph nodes predicts survival in esophageal cancer.
Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M
Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631
[TBL] [Abstract][Full Text] [Related]
28. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases.
Xiao ZF; Yang ZY; Miao YJ; Wang LH; Yin WB; Gu XZ; Zhang DC; Sun KL; Chen GY; He J
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):82-90. PubMed ID: 15850906
[TBL] [Abstract][Full Text] [Related]
29. [Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy].
Zhang DK; Su XD; Lin P
Ai Zheng; 2008 Feb; 27(2):113-8. PubMed ID: 18279605
[TBL] [Abstract][Full Text] [Related]
30. The influence of circumferential resection margin status on loco-regional recurrence in esophageal squamous cell carcinoma.
Park HJ; Kim HJ; Chie EK; Kang CH; Kim YT
J Surg Oncol; 2013 Jun; 107(7):762-6. PubMed ID: 23280705
[TBL] [Abstract][Full Text] [Related]
31. Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.
Ren Y; Su C; Zhou Y; Zhao X; Yang CL; Liu YY
World J Gastroenterol; 2014 Dec; 20(47):17970-5. PubMed ID: 25548496
[TBL] [Abstract][Full Text] [Related]
32. Postoperative radiotherapy after esophagectomy: ripe for a randomized trial.
Jiwnani S; Karimundackal G; Pramesh CS; Laskar SG
Ann Thorac Surg; 2011 May; 91(5):1652. PubMed ID: 21524496
[No Abstract] [Full Text] [Related]
33. A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma.
Taniyama Y; Nakamura T; Mitamura A; Teshima J; Katsura K; Abe S; Nakano T; Kamei T; Miyata G; Ouchi N
Ann Thorac Surg; 2013 Jun; 95(6):1930-7. PubMed ID: 23642437
[TBL] [Abstract][Full Text] [Related]
34. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
[TBL] [Abstract][Full Text] [Related]
35. Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma.
Hsu PK; Huang CS; Wang BY; Wu YC; Hsu WH
Ann Thorac Surg; 2014 May; 97(5):1734-41. PubMed ID: 24612702
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of lymph node metastasis in the thoracic esophageal squamous cell carcinoma].
Zhu ZJ; Zhao YF; Hu Y; Chen LQ; Liu LX; Wu Z; Kou YL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):138-40. PubMed ID: 18646699
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of the therapeutic effect of esophagectomy with extended 2-field lymph node dissection for esophageal carcinoma].
Wu CR; Xue HC; Zhu ZH; Zhang ZB; Geng CY; Ma ZK; Guo Y; Gao J
Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):630-3. PubMed ID: 20021954
[TBL] [Abstract][Full Text] [Related]
38. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
[TBL] [Abstract][Full Text] [Related]
39. Lymph node dissection for thoracic esophageal carcinoma. Two- and 3-field lymph node dissection.
Kato H
Ann Chir Gynaecol; 1995; 84(2):193-9. PubMed ID: 7574380
[TBL] [Abstract][Full Text] [Related]
40. An audit of surgical outcomes of esophageal squamous cell carcinoma.
Goan YG; Chang HC; Hsu HK; Chou YP
Eur J Cardiothorac Surg; 2007 Mar; 31(3):536-44. PubMed ID: 17222561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]